Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Seizure Topic Center

Featured Article

News
Febrile Seizure Risk Slightly Higher With Vaccine Combinations in Kids
06/08/2016
By Will Boggs MD NEW YORK (Reuters Health) - The risk of febrile seizures in children increases slightly when trivalent inactivated influenza vaccine (IIV3) is given in combination with pneumococcal conjugate vaccine (PCV) or a...
By Will Boggs MD NEW YORK (Reuters Health) - The risk of febrile seizures in children increases slightly when trivalent inactivated influenza vaccine (IIV3) is given in combination with pneumococcal conjugate vaccine (PCV) or a...
By Will Boggs MD NEW YORK...
06/08/2016
First Report Managed Care
News
Cannabidiol Drug Reduces Seizure Rate in New Study
03/18/2016
In a Phase III trial, the investigational medicine Epidiolex (cannabidiol, GW Pharmaceuticals plc) performed significantly better than placebo in reducing convulsive seizures in children with Dravet syndrome, a rare and severe form of...
In a Phase III trial, the investigational medicine Epidiolex (cannabidiol, GW Pharmaceuticals plc) performed significantly better than placebo in reducing convulsive seizures in children with Dravet syndrome, a rare and severe form of...
In a Phase III trial, the...
03/18/2016
First Report Managed Care
News
AI Tool for Drug Repurposing May Offer New Hope for Treating Rare and Neglected Diseases
09/27/2024
Harvard Medical School researchers unveil a potentially groundbreaking AI tool, TxGNN, that identifies potential drug candidates for 17 080 diseases, offering hope for patients with rare and neglected conditions.
Harvard Medical School researchers unveil a potentially groundbreaking AI tool, TxGNN, that identifies potential drug candidates for 17 080 diseases, offering hope for patients with rare and neglected conditions.
Harvard Medical School...
09/27/2024
First Report Managed Care
News
Impact of Multi-Drug Resistant Bacterial Infections on Patients With Bronchiectasis
09/27/2024
A study published in the Annals of Clinical Microbiology and Antimicrobials explores the impact of multidrug-resistant (MDR) bacterial infections on the clinical outcomes of adult patients with bronchiectasis, finding a significant increase...
A study published in the Annals of Clinical Microbiology and Antimicrobials explores the impact of multidrug-resistant (MDR) bacterial infections on the clinical outcomes of adult patients with bronchiectasis, finding a significant increase...
A study published in the Annals...
09/27/2024
First Report Managed Care
News
Understanding the Pharmacology and Clinical Application of siRNA Therapies
09/25/2024
Explore the state of siRNA-based therapies, relevant pharmacology insights, and care strategies aimed to enhance patient outcomes.
Explore the state of siRNA-based therapies, relevant pharmacology insights, and care strategies aimed to enhance patient outcomes.
Explore the state of siRNA-based...
09/25/2024
First Report Managed Care
News
Impact of Long-Term Acute Care Hospital Closures on Patient Care Patterns and Outcomes
09/23/2024
A study published in JAMA Network Open examines the impact of long-term acute care hospital closures on care patterns and outcomes for patients requiring mechanical ventilation, revealing changes in discharge patterns and advanced directive...
A study published in JAMA Network Open examines the impact of long-term acute care hospital closures on care patterns and outcomes for patients requiring mechanical ventilation, revealing changes in discharge patterns and advanced directive...
A study published in JAMA...
09/23/2024
First Report Managed Care
News
Treatment Combination Advances Metastatic Urothelial Cancer Care
09/23/2024
Recent data has established enfortumab vedotin (EV) and pembrolizumab (P) as the preferred first-line (1L) treatment option for patients with metastatic urothelial cancer, according to an article in American Society of Clinical Oncology...
Recent data has established enfortumab vedotin (EV) and pembrolizumab (P) as the preferred first-line (1L) treatment option for patients with metastatic urothelial cancer, according to an article in American Society of Clinical Oncology...
Recent data has established...
09/23/2024
First Report Managed Care
News
Investigational 4F-PCC Non-Inferior to Control for Vitamin K Antagonist Reversal
09/23/2024
An investigational 4-factor prothrombin complex concentrate (4F-PCC) was hemostatically non-inferior to a licensed control 4F-PCC for the rapid reversal of vitamin K antagonists (VKA) in patients needing urgent surgery, according to study...
An investigational 4-factor prothrombin complex concentrate (4F-PCC) was hemostatically non-inferior to a licensed control 4F-PCC for the rapid reversal of vitamin K antagonists (VKA) in patients needing urgent surgery, according to study...
An investigational 4-factor...
09/23/2024
First Report Managed Care
News
Exploring the Mechanisms of FDA-Approved siRNA Treatments in Disease Therapy
09/20/2024
Explore the groundbreaking advancements in RNA interference (RNAi) therapeutics, with a focus on the 6 US Food and Drug Administration (FDA)-approved small interfering RNA (siRNA) treatments and how they are revolutionizing disease treatment...
Explore the groundbreaking advancements in RNA interference (RNAi) therapeutics, with a focus on the 6 US Food and Drug Administration (FDA)-approved small interfering RNA (siRNA) treatments and how they are revolutionizing disease treatment...
Explore the groundbreaking...
09/20/2024
First Report Managed Care
News
High Mortality and Impairment Rates Among Older Adults in Long-Term Acute Care Hospitals
09/20/2024
Long-term acute care hospitals (LTCHs) provide critical, multidisciplinary care for medically complex patients, but survival rates and long-term functional outcomes remain poor, according to a study published in JAMA Network Open.
Long-term acute care hospitals (LTCHs) provide critical, multidisciplinary care for medically complex patients, but survival rates and long-term functional outcomes remain poor, according to a study published in JAMA Network Open.
Long-term acute care hospitals...
09/20/2024
First Report Managed Care
News
Addressing Stigma is Essential for Increasing PrEP Uptake and Adherence in HIV Prevention Efforts
09/20/2024
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated with pre-exposure prophylaxis (PrEP) is crucial for improving its uptake and adherence among eligible populations, according to study results published in Sexes.
Addressing stigma associated...
09/20/2024
First Report Managed Care
News
UC Davis Health Unveils Innovative Strategy to Shield Patients With COPD and Asthma From Wildfire Hazards
09/20/2024
As wildfires become an annual threat due to climate change, health systems must proactively adopt air quality-focused population health approaches to protect vulnerable patients with chronic respiratory conditions like COPD and asthma,...
As wildfires become an annual threat due to climate change, health systems must proactively adopt air quality-focused population health approaches to protect vulnerable patients with chronic respiratory conditions like COPD and asthma,...
As wildfires become an annual...
09/20/2024
First Report Managed Care

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement